Purpose: Understanding the spectrum of pathogens in a given geographic region is important when deciding on empiric antibiotic therapy. In this study, we evaluate the spectrum of bacterial organisms cultured from corneal samples and their antibiotic sensitivities to guide initial treatment of keratitis.
U nderstanding the spectrum of pathogens in a given geographic region is important when deciding on initial antibiotic therapy. [1] [2] [3] [4] [5] Causes of infectious keratitis vary depending on climate and other risk factors such as contact lens wear or risk of trauma with vegetative material. 6 Because untreated bacterial keratitis can lead to corneal perforation, endophthalmitis, and eventual loss of the eye, empiric antibiotic treatment is initiated before a specific causative organism can be identified.
In the literature and within our own institution, there has been debate regarding the use of commercially available fourth-generation fluoroquinolones versus compounded fortified antibiotics. Several randomized controlled trials have shown equivalency between these therapies. [7] [8] [9] [10] [11] Notably, these trials were conducted in developing countries where resistant organisms are less common. The use of fortified antibiotics in the United States remains prevalent. 12, 13 In this study, we report the spectrum of bacterial organisms isolated from corneal cultures and their antibiotic resistance patterns from one tertiary care center in Northern California: the Francis I. Proctor Microbiology Laboratory at the University of California, San Francisco.
METHODS
After institutional research board approval was obtained from the University of California, San Francisco (UCSF), records of all corneal cultures performed and sent to the Francis I. Proctor Microbiology Laboratory from January 1, 1996, to September 31, 2015, were retrospectively reviewed. Corneal samples from infectious keratitis cases at the Proctor Foundation and at UCSF cornea clinics were collected in a standardized manner by performing gram staining and aerobic culture by inoculating blood and chocolate agar plates. Culture plates were incubated at 35°C in 10% CO 2 and examined daily for up to 7 days.
Cultures were considered positive when they met the following criteria: 1) the same organism was isolated on 2 or more media, 2) an isolate was present on one medium and associated with the identification of the same organism on gram-stained direct smears, 3) heavy growth at the inoculation site on one solid medium, 4) isolation of organisms consistent with normal flora such as coagulase-negative Staphylococcus and Corynebacterium spp. was considered significant only if there was moderate or numerous growth on 2 solid media. Antibiotic susceptibilities of microbiological isolates were determined according to disc susceptibility testing guidelines set forth by the Clinical and Laboratory Standards Institute (CLSI) and categorized as sensitive, intermediate, or resistant. In circumstances when CLSI interpretive standards were not available, Federal Drug Administration-approved zone diameters were used. When applicable, CLSI interpretive standards for Staphylococcus were used for antibiotics without interpretive standards for Streptococcus spp., and interpretive standards for Enterobacteriaceae were used to interpret antibiotics without interpretive standards for gram-negative rods. Susceptibility testing was conducted for the following antibiotics: bacitracin, cephalothin, erythromycin, sulfisoxazole, oxacillin, tetracycline, tobramycin, vancomycin, trimethoprim, ciprofloxacin, moxifloxacin, gatifloxacin, ofloxacin, neomycin, tobramycin, ampicillin, ceftazidime, gentamicin, and polymyxin.
Isolated organisms were grouped into 1 of 10 classes for the purpose of our analysis: 1) Staphylococcus species, 2) Streptococcus species (including Streptococcus pneumonia, Streptococcus viridans, nonhemolytic streptococci, nutritionally variant Streptococci, beta hemolytic Streptococcus group A, beta hemolytic Streptococcus group B), 3) enterics (including Proteus penneri, Proteus mirabilis, Klebsiella pneumonia, Klebsiella oxytoca, Serratia species, Serratia marcescens, Serratia liquefaciens, Enterobacter species, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Morganella morganii, Citrobacter species, 4) Pseudomonas species, 5) Nocardia species, 6) Mycobacterium species, 7) coagulase-negative Staphylococcus, 8) Haemophilus species, 9) gram-negative rods, and 10) Diphtheroids.
A logistic regression model was used to assess whether there was an increase in the risk of culturing methicillinresistant Staphylococcus aureus (MRSA) among Staphylococcus ulcers over time. Similarly, a logistic regression model was used to evaluate the association between the year cultured and moxifloxacin resistance after controlling for the infectious organism. An alpha of ,0.05 was considered statistically significant. All statistical analyses were conducted using Stata version 14.0.
RESULTS
A total of 2203 aerobic corneal cultures were performed over a 19-year period from 1996 to 2015. Of these, 1342 (62.2%) resulted in no isolation of aerobic bacteria, 27 (1.3%) isolated normal flora believed to represent contamination, 10 grew acid-fast bacteria (0.4%), and 302 (14%) grew in culture but did not grow during sensitivity testing and therefore sensitivity data were not available. Four (0.008%) cultures grew fungus and were not included in the subsequent analyses. Therefore, 522 cultures (23.7%) grew bacteria that were believed to be causing infectious keratitis (ie, not a result of contamination), which had available sensitivity data and were included in this analysis. Table 1 outlines the 5 most commonly isolated gram-positive organisms and their antibiotic susceptibility profiles. Methicillin-sensitive Staphylococcus aureus (MSSA) represented approximately 20% (N = 105) of all isolates in our series. These organisms were susceptible to the majority of commonly used antibiotics. MRSA were cultured about 5% (N = 26) of the time. These organisms had inconsistent in vitro susceptibility to commonly used antibiotics such as fluoroquinolones. All oxacillin-resistant Staphylococcus are considered resistant to all current beta-lactam antimicrobial agents regardless of in vitro results, with the exception of the newer cephalosporins with an anti-MRSA activity. MRSA isolates had good in vitro sensitivity to trimethoprim (96%) and sulfisoxazole (100%) and, as expected, they were 100% sensitive to vancomycin. Coagulase-negative staphylococci were also commonly isolated (N = 52) and had variable sensitivity to cephalosporins (65%) and fluoroquinolones (42%-100%). Most frequently isolated gram-positive organisms isolated in culture. The numerator displays the number of samples sensitive to the listed antibiotic, and the denominator represents the total number of the organism isolated. Percent sensitivity to the antibiotic is shown in the parenthesis.
Of note, ofloxacin was tested in Streptococcus, and ciprofloxacin was tested against all other gram-positive organisms. *Were not tested as they were assumed to be resistant. †In 2010, the CLSI stopped reporting vancomycin susceptibilities with regard to MRSA because disc diffusion was not shown to be effective in determining susceptibility.
Moxifloxacin provided good coverage against most other tested gram-positive organisms. Table 2 outlines the 5 most commonly isolated gramnegative bacteria and their antibiotic susceptibility profiles. Pseudomonas species (N = 57) were the most commonly cultured gram-negative organisms. Pseudomonas exhibited excellent in vitro sensitivity to fluoroquinolones (94%-98%) as did Serratia, Moraxella, and other enteric organisms. NonMoraxella gram-negative rods (N = 46) demonstrated better in vitro susceptibility to ceftazidime (100%) than to tobramycin (30%) or moxifloxacin (67%).
The risk of culturing MRSA from corneal cultures seemed to increase over time in this urban tertiary care center. Among Staphylococcus species, there was 1.13 increased odds of culturing MRSA for each 1-year increase in the culture date (P = 0.01). Resistance to moxifloxacin also increased over time since its introduction to our laboratory in 2005 with a 1.26-fold increase in culturing an organism that was resistant to moxifloxacin with each 1-year increase in the culture date even after controlling for the type of the organism (P , 0.001). A sensitivity analysis accounting for autocorrelation did not appreciably change our results. Figure 1 demonstrates the percentage of isolated Streptococcus and Staphylococcus samples with moxifloxacin resistance as parsed by year.
DISCUSSION
We report the spectrum of bacterial organisms isolated from corneal cultures at the microbiology laboratory of one tertiary ophthalmic care center in Northern California. We found that 65.3% of isolated organisms with sensitivity data were gram positive with MSSA being the most common. Although MRSA represented only approximately 5% of the isolated organism in our series, the risk of culturing MRSA also seemed to be increasing in our population. Approximately 26% of isolated gram-positive organisms had inconsistent susceptibility to moxifloxacin and other fluoroquinolones, and the risk of culturing organisms resistant to moxifloxacin seemed to increase over time. Therefore, fluoroquinolone monotherapy, may not be appropriate empiric treatment in an urban tertiary hospital such as ours. However, the choice between empiric fortified antibiotics versus fluoroquinolone monotherapy in the treatment of bacterial ulcers is complex and depends on drug availability, practice setting (university vs. private), Most frequently isolated gram-negative organisms in the culture. The numerator displays the number of samples sensitive to the listed antibiotic, and the denominator represents the total number of the organism isolated. Percent sensitivity to the antibiotic is shown in the parenthesis. geographic location (city vs. rural), and risk of MRSA in the community.
Given the results of our study, 2 recommendations can be made: 1) corneal cultures are important to identify the infectious organism and test for antibiotic sensitivities, and 2) whether starting with fortified antibiotics or with fluoroquinolone monotherapy initially, follow-up of culture results and clinical response is essential. If the bacterial species is resistant to fluoroquinolone monotherapy on culture or if the infection is not responding clinically, the patient must be switched to fortified antibiotics. If the patient was initially administered fortified antibiotics but cultures reveal an organism that is sensitive to fluoroquinolones, switching is prudent given the ocular surface toxicity associated with fortified antibiotics. It is our strong recommendation that no one should be on high doses of fortified antibiotics for more than 1 week without either tapering or tailoring therapy.
Our results seem consistent with previous studies demonstrating predominance of gram-positive organisms, and in particular MSSA. Staphylococcus aureus has been reported to be the most common cause of bacterial keratitis in the United States, 14 United Kingdom, 15 and Brazil. 16 Increasing rates of MRSA in ocular infections have also been reported in other series, representing even up to 45% of Staphylococcus aureus isolates. 17 Increased resistance of these organisms to fluoroquinolones has also been reported previously. [18] [19] [20] [21] [22] [23] In our hands, pseudomonas displayed excellent sensitivity to fluoroquinolones. This is in contrast to other studies that suggested that pseudomonas species are also developing resistance. 24, 25 The strengths of this study include the fact that we report corneal culture results and antibiotic susceptibilities on a large number of cultures over a long period at an ophthalmologyspecific microbiology laboratory. Limitations are that these results report in vitro antibiotic susceptibilities and we did not correlate this with clinical response to treatment. However, clinical outcomes such as visual acuity and scar size have been associated with in vitro susceptibility patterns previously. 26 These organisms were cultured from a tertiary care center in an urban part of Northern California and may not be generalizable to other regions of the United States or to rural settings. Our rate of bacterial culture positivity was 37.8%, which is relatively low. We attribute this to the fact that many patients with infectious keratitis are administered antibiotics before being referred to our institution. We also maintain strict protocols to distinguish between true culture-positive results and contaminants, which dropped the rate of organism recovery. Given referral bias, some patients may have had positive cultures despite antibiotic therapy; therefore, organisms with antibiotic resistance may be overrepresented in our series.
In summary, we describe a retrospective review of positive corneal cultures performed in one tertiary care center in Northern California, which demonstrates predominance of gram-positive organisms. Over time, we observed an increase in fluoroquinolone-resistant organisms, which we could not attribute to the increase in prevalence of MRSA alone.
